Compass Therapeutics (CMPX) Capital Expenditures (2020 - 2026)
Compass Therapeutics' Capital Expenditures was $176,000 in Q2 2026, up 114.6% from the prior quarter.
Powered by 
Analysis
Compass Therapeutics (CMPX) Capital Expenditures (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Compass Therapeutics' Capital Expenditures was $265,000 through Jun 30, 2026, up 327.4% year-over-year; for FY2025, it was $25,000, down 43.2% from FY2024.
- Capital Expenditures shows a five-year compound annual growth rate of -25.1% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $44,000 in FY2024 (+46.7%), $30,000 in FY2023 (-85.8%), $212,000 in FY2022 (-86.5%) and $1.57 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Capital Expenditures since Q1 2022.
- The best year-over-year quarter for Capital Expenditures over five years was Q1 2026 (growth of 355.6%); the worst was Q4 2022 (a decline of 93.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.10 Bn | 1,100.69 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 615.67 Bn | 534.20 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 504.61 Bn | 477.72 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 368.03 Bn | 322.41 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.24 Bn | 262.23 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.77 Bn | 235.46 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 236.17 Bn | 191.57 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 190.62 Bn | 164.81 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Compass Therapeutics | 156.24 Mn | -649.40 Mn | - | 176,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 176,000.00 |
| Mar 31, 2026 | 82,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Sep 30, 2024 | 44,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Jun 30, 2023 | 11,000.00 |
| Dec 31, 2022 | 54,000.00 |
| Sep 30, 2022 | 27,000.00 |
| Jun 30, 2022 | -63,000.00 |
| Mar 31, 2022 | 194,000.00 |
| Dec 31, 2021 | 777,000.00 |
| Sep 30, 2021 | 367,000.00 |
| Mar 31, 2021 | 128,000.00 |
| Mar 31, 2020 | 12,000.00 |
API Access
Compass Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CMPX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "CMPX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CMPX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();